Lurasidone

Back to search

Molecule Structure

Scientific Name

Lurasidone

Description of the Drug

Lurasidone is an atypical antipsychotic used to treat schizophrenia and depressive episodes associated with bipolar I disorder.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08815

Brand Name(s)

Latuda

Company Owner(s)

Amneal Pharmaceuticals Co Gmbh, Teva Pharmaceuticals Usa Inc, Alembic Pharmaceuticals Ltd, Piramal Healthcare Uk Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Invagen Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Accord Healthcare Inc, Dr Reddys Laboratories Ltd, Emcure Pharmaceuticals Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dopamine D2 receptor SINGLE PROTEIN ANTAGONIST CHEMBL217
Serotonin 2a (5-HT2a) receptor SINGLE PROTEIN ANTAGONIST CHEMBL224

Unichem Links

SureChEMBL SCHEMBL677525
PharmGKB PA166129557
DrugBank DB08815
PubChem: Thomson Pharma 16247346
PubChem 213046
LINCS LSM-45843
Nikkaji J2.437.646J
BindingDB 85222
DrugCentral 4168
ChemicalBook CB22498821 CB32500192
Guide to Pharmacology 7461
rxnorm LURASIDONE HYDROCHLORIDE LURASIDONE LATUDA
ChEBI 70735
ZINC ZINC000003927822